Quantitation of HIV-1 group M proviral DNA using TaqMan MGB real-time PCR

Journal of Virological Methods

Volumn 157, Issue 2, 2009, Pages 141-146

  Kondo, Makiko ^a   Sudo, Koji ^b   Tanaka, Rie ^b   Sano, Takako ^a   Sagara, Hiroko ^c   Iwamuro, Shinya ^d   Takebe, Yutaka ^e   Imai, Mitsunobu ^a   Kato, Shingo ^b  

^a KANAGAWA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

^d Atsugi City Hospital   (Japan)

^e NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Degenerate primer; HIV 1 DNA quantitation; Real time PCR

Indexed keywords

CELL DNA; VIRUS DNA;

ACCURACY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DILUTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; POISSON DISTRIBUTION; PRIORITY JOURNAL; PROVIRUS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SENSITIVITY ANALYSIS; VALIDATION STUDY; VIRUS DETECTION; VIRUS LOAD;

DNA PRIMERS; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROVIRUSES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 63449119880     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2008.12.006     Document Type: Article

References (27)

1. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., and Martin M. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59 (1986) 284-291
2. Burgard M., Izopet J., Dumon B., Tamalet C., Descamps D., Ruffault A., Vabret A., Bargues G., Mouroux M., Pellegrin I., Ivanoff S., Guisthau O., Calvez V., Seigneurin J.M., and Rouzioux C. HIV RNA and HIV DNA in peripheral blood mononuclear cells are consistent markers for estimating viral load in patients undergoing long-term potent treatment. AIDS Res. Hum. Retroviruses 10 (2000) 1939-1947
3. Carr J.M., Cheney K.M., Coolen C., Davis A., Shaw D., Ferguson W., Chang G., Higgins G., Burrell C., and Li P. Development of methods for coordinate measurement of total cell-associated and integrated human immunodeficiency virus type 1 (HIV-1) DNA forms in routine clinical parameters, but low levels of integrated HIV-1 DNA may be prognostic for continued successful therapy. J. Clin. Microbiol. 45 (2007) 1288-1297
4. Chun T.W., Stuyver L., Mizell S.B., Ehler L.A., Mican M., Baseler M., Lloyd A.L., Nowak M.A., and Fauci A.S. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 13193-13197
5. Coste J., Montes B., Reynes J., Peeters M., Segarra C., Vendrell J.P., Delaporte E., and Segondy M. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Med. Virol. 50 (1996) 293-302
6. De Milito A., Titanji K., and Zazzi M. Surrogate markers as a guide to evaluate response to antiretroviral therapy. Curr. Med. Chem. 10 (2003) 349-365
7. Désiré N., Dehée A., Schneider V., Jacomet C., Goujon C., Girad P.-M., Rozenbaum W., and Nicolas J.-C. Quantification of human immunodeficiency virus type 1 proviral load by a TaqMan real-time PCR assay. J. Clin. Microbiol. 39 (2001) 1303-1310
8. Gallant J.E., DeJesus E., Arribas J.R., Pozniak A.L., Gazzard B., Campo R.E., Lu B., McColl D., Chuck S., Enejosa J., Toole J.J., Cheng A.K., and for the Study 934. Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV. N. Engl. J. Med. 354 (2006) 251-260
9. Gibellini D., Vitone F., Schiavone P., Ponti C., La Placa M., and Re M.C. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique. J. Clin. Virol. 29 (2004) 282-289
10. Felsenstein J. PHYLIP-phylogeny inference package (version 3.2). Cladistics 5 (1989) 164-166
11. Kabamba-Mukadi B., Henrivaux P., Ruelle J., Delferrière N., Bodéus M., and Goubau P. Human immunodeficiency virus type 1 (HIV-1) proviral DNA load in purified CD4+ cells by LightCycler real-time PCR. BMC Infect. Dis. 5 (2005) 15-23
12. Kato S., Hanabusa H., Kaneko S., Takakuwa K., Suzuki M., Kuji N., Jinno M., Tanaka R., Kojima K., Iwashita M., Yoshimura Y., and Tanaka K. Complete removal of HIV-1 RNA and proviral DNA from semen by the swim-up method: assisted reproduction technique using spermatozoa free from HIV-1. AIDS 20 (2006) 967-973
13. Kinai E., Hanabusa H., and Kato S. Prediction of the efficacy of antiviral therapy for hepatitis C virus infection by an ultrasensitive RT-PCR assay. J. Med. Virol. 79 (2007) 1113-1119
14. Kondo M., Shima T., Nishizawa M., Sudo K., Iwamuro S., Okabe T., Takebe Y., and Imai M. Identification of attenuated variants of HIV-1 circulating recombinant from 01_AE that are associated with slow disease progression due to gross genetic alterations in the nef/long terminal repeat sequences. J. Infect. Dis. 192 (2005) 56-61
15. Kusakawa S., Sato H., Tomita Y., Tatsumi M., Kato K., Motomura K., Yang R., and Takebe Y. Isolation and characterization of replication-competent molecular DNA clones of HIV type 1 CRF01_AE with different coreceptor usages. AIDS Res. Hum. Retroviruses 18 (2002) 115-122
16. Mellors J.W., Rinaldo Jr. C.R., Gupta P., White R.M., Todd J.A., and Kingsley L.A. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272 (1996) 1167-1170
17. Michael N., Herman S.A., Kwok S., Dreyer K., Wang J., Christopherson C., Spadoro J.P., Young K.K.Y., Polonis V., McCutchan F.E., Carr J., Mascola J.R., Jagodzinski L.L., and Robb M.L. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR MONITOR test with isolates of diverse subtypes. J. Clin. Microbiol. 37 (1999) 2557-2563
18. Murphy D.G., Gonin P., and Fauvel M. Reproducibility and performance of the second-generation branched DNA assay in routine quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 37 (1999) 812-814
19. Pantaleo G., Graziosi C., and Fauci A.S. New concepts in the immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328 (1993) 327-335
20. Pellegrin I., Caumont A., Garrigue I., Merel P., Schrive M.H., Fleury H., Dupon M., Pellegrin J.L., and Ragnaud J.M. Predictive value of proviral load and DNA human immunodeficiency virus genotype for successful abacavir-based simplified therapy. J. Infect. Dis. 187 (2003) 38-46
21. Rodríguez B., Sethi A.K., Cheruvu V.K., Mackay W., Bosch R.J., Kitahata M., Boswell S.L., Mathews W.C., Bangsberg D.R., Martin J., Whalen C.C., Sieg S., Yadavalli S., Deeks S.G., and Lederman M.M. Predictive value of plasma HIV RNA level on rate of CD4 T-cell decline in untreated HIV infection. JAMA 296 (2006) 1498-1506
22. Saha B.K., Tian B., and Bucy R.P. Quantitation of HIV-1 by real-time PCR with a unique fluorogenic probe. J. Virol. Methods 93 (2001) 33-42
23. Simmonds P., Balfe P., Ludlam C.A., Bishop J.O., and Brown A.J. Human immunodeficiency virus-infected individuals contain provirus in small numbers of peripheral mononuclear cells and at low copy numbers. J. Virol. 64 (1990) 864-872
24. Sonza S., Mutimer H.P., Oelrichs R., Jardine D., Harvey K., Dunne A., Purcell D.F., Birch C., and Crowe S.M. Monocytes harbour replication-competent non-latent HIV-1 in patients on highly active antiretroviral therapy. AIDS 15 (2001) 17-22
25. Soriano-Sarabia N., Vallejo A., Fernández G., Genebat M., Gutiérrez S., Muñoz-Fernández M.A., and Leal M. Control of HIV-1 RNA load after HAART interruption: relationship with CCR5 co-receptor density and proviral DNA load in HIV-infected patients. J. Clin. Virol. 40 (2007) 64-67
26. Yun Z., Fredriksson E., and Sönnerborg A. Quantification of human immunodeficiency virus type 1 proviral DNA by the TaqMan real-time PCR assay. J. Clin. Microbiol. 40 (2002) 3883-3884
27. Zhao Y., Yu M., Miller J.W., Chen M., Bremer E.G., Kabat W., and Yogev R. Quantification of human immunodeficiency virus type 1 proviral DNA by using TaqMan technology. J. Clin. Microbiol. 40 (2002) 675-678